Article Sidebar
Published:
Jun 25, 2024Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Efficacy of Lactobacillus live capsules in combination with metronidazole for the treatment of bacterial vaginosis
Abstract
Purpose: To evaluate the effectiveness of metronidazole in combination with Lactobacillus live capsules for the treatment of bacterial vaginosis (BV).
Methods: A retrospective study of 100 BV patients was conducted between June 2020 and February 2022 at Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China. Patients were assigned to control (48 patients received metronidazole only) and study groups (52 patients received metronidazole and Lactobacillus live capsules). Short-term efficacy, changes in vaginal flora distribution, recurrence rates, and occurrence of adverse effects were investigated.
Results: The study group showed significantly higher overall efficacy compared to control group (p < 0.05). After treatment, vaginal flora analysis revealed a more balanced microbiota in the study group, indicating a positive effect of combined therapy. However, recurrence rates at one and three months after treatment did not significantly differ between the two groups (p > 0.05). Both treatment regimens were generally well-tolerated, with only a single report of mild adverse reactions in the study group.
Conclusions: The combined therapy of metronidazole and Lactobacillus live capsules enhances shortterm therapeutic effectiveness and promotes a healthier vaginal microbiota. Although, the combined therapy does not significantly impact recurrence rates, it demonstrates a favorable safety profile. The lack of attention to non-bacterial constituents of the vaginal flora and potential long-term adverse effects of Lactobacillus live capsules represent an area for future study.
